An increase in cerebrospinal fluid macrophage migration inhibitory factor levels in pediatric patients with acute neuroinflammatory diseases: A preliminary study | Synapse
March 3, 2026
An increase in cerebrospinal fluid macrophage migration inhibitory factor levels in pediatric patients with acute neuroinflammatory diseases: A preliminary study
Key Points
Increased cerebrospinal fluid levels of macrophage migration inhibitory factor indicate a significant immune response in neuroinflammatory conditions.
The study shows a 35% rise in macrophage migration inhibitory factor levels compared to controls.
Observational analysis of pediatric patients with acute neuroinflammatory diseases was conducted to assess biomarker levels.
Findings highlight the need for further exploration of macrophage migration inhibitory factor as a diagnostic tool in clinical practice.